Kurbatova EV, Whitworth WC, Peddareddy LP, Phillips PPJ, et al. Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes. Emerg Infect Dis 2025;31:467-476.
PMID: 40023788